ADVERTISEMENT
ADVERTISEMENT
Aspen Neuroscience hires Revati Shreeniwas as CMO
The Indian-American physician will lead late-stage Parkinson’s therapy development at Aspen Neuroscience.
-
1759163132.png)
Anushka Pathak - Wed, 07, Jan 2026
- 15:21 EST
- 24
Revati Shreeniwas / Courtesy: LinkedIn
California-based biotechnology company Aspen Neuroscience has appointed Indian-American physician Revati Shreeniwas as its chief medical officer.
She will lead clinical, regulatory, and medical affairs as the company advances its investigational therapy for Parkinson’s disease.
The company said the appointment supports its move toward late-stage development and commercial readiness for its autologous induced pluripotent stem cell-derived program. Lisa Johnson-Pratt was also named chief commercial officer.
Also Read: Hoboken Mayor Bhalla to join Dundon Advisers as MD
Shreeniwas brings more than 20 years of experience in biopharma leadership, with oversight of over 40 clinical trials and multiple registration programs across neurology, neurodegeneration, and central nervous system disorders. Her prior work includes contributions to the development and commercialization of therapies such as RYTARY for Parkinson’s disease.
“Aspen's autologous iPSC-derived approach is redefining what's possible in neurodegenerative disease,” Shreeniwas said. “I'm excited to help deliver a rigorous registrational program for Parkinson's patients, partnering across clinical, regulatory, technical operations, and medical affairs.”
Before joining Aspen Neuroscience, Shreeniwas served as chief medical officer at Cystetic Medicines, Excision BioTherapeutics, Bright Minds Biosciences, Soleno Therapeutics, and ImmunoMet Therapeutics. Earlier, she held faculty appointments at Columbia University and Stanford University before transitioning from clinical practice to industry roles.
She earned her medical degree from the Armed Forces Medical College in Pune and completed her internal medicine residency at UMass Chan Medical School, followed by fellowships in pulmonary disease and critical care medicine at New York Presbyterian Hospital, Columbia campus.
Related
.jpg)
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login